Prevalence of non-T-cells in the replication of the N-tropic, type C virus of young AKR mice
Gisselbrecht, S.; Blaineau, C.; Hurot, M.A.; Pozo, F.; Levy, J.P.
Cancer Research 38(4): 939-941
1978
ISSN/ISBN: 0008-5472 PMID: 205350 Document Number: 130978
The XC infectious center assay was used to study the nature of the lymphoid cells producing N-tropic C-type viruses in preleukemic AKR mice. Viral production by thymic cell suspensions was very low and was possibly due to contaminating cells. Production at least 100-fold higher was found in spleen cells and was probably due to non-T-cells. The significance of these results is discussed briefly, including the possibility that the N-tropic XC syncitia-inducing type C virus of young AKR mice is not the leukemogenic agent.
Document emailed within 1 workday
Related Documents
Pusateri, A.M.; Ewalt, L.C.; Lodmell, D.L. 1980: Nonspecific inhibition of encephalomyocarditis virus replication by a type Ii interferon released from unstimulated cells of Mycobacterium tuberculosis-sensitized mice Journal of Immunology 124(3): 1277-1283Muratore, O.; Pesce-Schito, A.; Mosti, L.; Sansebastiano, L.; Schito, G.C. 1991: S-7 inhibition of Herpes simplex virus type 1 infectivity and replication in cultured cells Journal of ChemoTherapy 3(Suppl 1): 84-85
Muratore, O.; Pesce Schito, A.; Tonoli, E.L.; Gianoglio, S.; Mosti, L. 1998: Antiviral activity of FA-11H on the infectivity and replication of herpes simplex virus type 1 in cultured cells New Microbiologica 21(3): 275-279
Mancino, G.; Placido, R.; Bach, S.; Mariani, F.; Montesano, C.; Ercoli, L.; Zembala, M.; Colizzi, V. 1997: Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells Journal of Infectious Diseases 175(6): 1531-1535
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Jolly, P.E.; Huang, L.; Chen, S. 2001: Neutralization/enhancement of macrophage-tropic SIVmac infection by plasma from macaques infected with macrophage-tropic or lymphocyte-tropic SIVmac Cellular and Molecular Biology 47(6): 997-1008
Dreĭzin, R.S.; Zhuravel', T.F.; Shalunova, N.V.; Klenova, A.V.; Zolotarskaia, E.E. 1979: Helper viruses of adeno-associated virus type 4 replication Voprosy Virusologii 1: 43-48
Yoosook, C.; Bhattarakosol, P.; Wilairat, P.; Sriurairatna, S. 1994: Encapsidation defectiveness of herpes simplex virus type 2 during replication at acid pH condition Asian Pacific Journal of Allergy and Immunology 12(1): 59-64
Grinev, A.A.; Samokhvalov, E.I.; Petrov, N.A.; Vasilenko, S.K.; Iuferov, V.P. 1988: Changes in the amino acid sequence of hemagglutinin during sequential adaptation of human influenza virus A to replication in mice Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 1988(9): 43-45
Alber, D.G.; Greensill, J.; Killington, R.A.; Stokes, A. 1995: Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice Research in veterinary science 59(3): 205-213
Li, W.; Zhang, Y.; Wang, S. 2001: Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 15(1): 61-65
Rajcáni, J.; Mayer, V.; Weismanová, E. 1982: Restricted replication of the E5"14" clone of Langat TP21 virus (from the tick-borne encephalitis complex) in CNS of subadult mice Acta Virologica 26(6): 488-496
Grófová, M.; Popovic, M.; Matoska, J.; Nilsson, K.; Vlasenkova, N.K.; Thurzo, V. 1979: Preferential replication of murine xenotropic type-C virus in human lymphosarcoma-derived cell lines Neoplasma 26(3): 241-250
Huang, W.; Tian, H-wen.; Ren, J.; Fan, J-tao.; Zhao, L.; Bian, T.; Lu, Z-hua.; Ruan, L. 2005: Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins Zhonghua Shi Yan He Lin Chuang Bing du Xue Za Zhi 19(3): 240-243
Rollwagen, F.M.; Stutman, O. 1985: Culture-generated suppressor cells: the same lineage as the source of suppressor cells derived from young mice and adult mice Transplantation 39(5): 554-555
Schlesinger, R.W. 1975: Sindbis virus replication in vertebrate and mosquito cells: an interpretation Medical Biology 53(5): 295-301
Liu, M.Y.; Chen, J.Y.; Yang, C.S. 1984: Activity of DNase associated with replication of Epstein-Barr virus in NPC-204 cells Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 17(3): 121-130
Blanc-Brunat, N.; Laurin, D.; Vivier, G.; Touraine, J.L.; Sergeant, A.; Garnier, J.L. 1995: Epstein-Barr virus lymphoblastoid cell lines from transplanted patients induce B lymphomas in SCID/hu mice: study of EBV replication Transplantation Proceedings 27(2): 1776
Baginski, I.; Colson, G.; Lavelle, F.; Zerial, A. 1985: Use of permeabilized cells in the study of inhibitory products of herpes virus replication Pathologie-Biologie 33(5 Part 2): 618-622